Differentiation of follicular thyroid adenoma from carcinoma by means of gene expression profiling with adapter-tagged competitive polymerase chain reaction

被引:16
作者
Taniguchi, K
Takano, T
Miyauchi, A
Koizumi, K
Ito, Y
Takamura, Y
Ishitobi, M
Miyoshi, Y
Taguchi, T
Tamaki, Y
Kato, K
Noguchi, S
机构
[1] Nara Inst Sci & Technol, Taisho Lab Funct Genom, Nara 63001, Japan
[2] Kuma Hosp, Kobe, Hyogo, Japan
[3] Osaka Univ, Dept Lab Med, Grad Sch Med, Osaka, Japan
[4] Osaka Univ, Osaka Med Ctr Canc & Cardiovasc Dis, Grad Sch Med, Osaka, Japan
[5] Osaka Univ, Dept Breast & Endocrine Surg, Grad Sch Med, Osaka, Japan
关键词
differential diagnosis; follicular tumor; gene expression profile; thyroid cancer;
D O I
10.1159/000089998
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Since preoperative differentiation between follicular thyroid adenoma (FTA) and carcinoma (FTC) remains very difficult, the purpose of this study was to identify the genes differentially expressed in FTA and FTC in order to construct a diagnostic system based on such genes for differentiation of FTA and FTC. Methods: Gene expression profiles of 45 FTAs and 22 FTCs were analyzed by means of adapter-tagged competitive polymerase chain reaction (ATAC-PCR) with 2,516 genes ( learning set). The genes differentially expressed in FTAs and FTCs were then used to construct a diagnostic system based on the weighted-voting algorithm. In addition, a validation study of this diagnostic system was conducted using 12 FTAs and 6 FTCs ( validation set). Results: The diagnostic system for differentiation of FTA and FTC, constructed with the aid of the learning set samples, was based on 60 genes differentially expressed in FTA and FTC, which included several genes previously identified as overexpressed in FTC (DPP4, KRT19 and IGFBP3) or FTA ( trefoil factor 3 and thyroid peroxidase). The leave-one-out cross-validation study showed that the accuracy of this diagnostic system was as high as 90% ( sensitivity: 77.3% and specificity: 95.6%), and was confirmed by the validation study ( diagnostic accuracy: 83.3%; 95% confidence interval: 62.8 - 95.4%, sensitivity: 66.7% and specifi city: 91.2%). Conclusions: This diagnostic system using the ATAC-PCR assay is expected to be clinically useful for preoperative differentiation between FTA and FTC since ATAC-PCR can be used for the small amount of RNA obtained from fine needle aspiration biopsy. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:428 / 435
页数:8
相关论文
共 35 条
[1]   DIPEPTIDYL AMINOPEPTIDASE-IV STAINING OF CYTOLOGIC PREPARATIONS TO DISTINGUISH BENIGN FROM MALIGNANT THYROID-DISEASES [J].
ARATAKE, Y ;
KOTANI, T ;
TAMURA, K ;
ARAKI, Y ;
KURIBAYASHI, T ;
KONOE, K ;
OHTAKI, S .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1991, 96 (03) :306-310
[2]   Diagnosis of "follicular neoplasm": A gray zone in thyroid fine-needle aspiration cytology [J].
Baloch, ZW ;
Fleisher, S ;
LiVolsi, VA ;
Gupta, PK .
DIAGNOSTIC CYTOPATHOLOGY, 2002, 26 (01) :41-44
[3]  
Barden CB, 2003, CLIN CANCER RES, V9, P1792
[4]   Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions [J].
Bartolazzi, A ;
Gasbarri, A ;
Papotti, M ;
Bussolati, G ;
Lucante, T ;
Khan, A ;
Inohara, H ;
Marandino, F ;
Orlandi, F ;
Nardi, F ;
Vecchione, A ;
Tecce, R ;
Larsson, O .
LANCET, 2001, 357 (9269) :1644-1650
[5]   Cytokeratin 19 and galectin-3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules [J].
Beesley, MF ;
McLaren, KM .
HISTOPATHOLOGY, 2002, 41 (03) :236-243
[6]   Determination of galectin-3 messenger ribonucleic acid overexpression in papillary thyroid cancer by quantitative reverse transcription-polymerase chain reaction [J].
Bernet, VJ ;
Anderson, J ;
Vaishnav, Y ;
Solomon, B ;
Adair, CF ;
Saji, M ;
Burman, KD ;
Burch, HB ;
Ringel, MD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (10) :4792-4796
[7]   A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression [J].
Cerutti, JM ;
Delcelo, R ;
Amadei, MJ ;
Nakabashi, C ;
Maciel, RMB ;
Peterson, B ;
Shoemaker, J ;
Riggins, GJ .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (08) :1234-1242
[8]  
Cvejic D, 1998, ANTICANCER RES, V18, P2637
[9]   TUMOR-SUPPRESSOR GENES IN HUMAN THYROID NEOPLASMS - P53 MUTATIONS ARE ASSOCIATED UNDIFFERENTIATED THYROID CANCERS [J].
FAGIN, JA .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1995, 18 (02) :140-142
[10]   Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring [J].
Golub, TR ;
Slonim, DK ;
Tamayo, P ;
Huard, C ;
Gaasenbeek, M ;
Mesirov, JP ;
Coller, H ;
Loh, ML ;
Downing, JR ;
Caligiuri, MA ;
Bloomfield, CD ;
Lander, ES .
SCIENCE, 1999, 286 (5439) :531-537